← Open Payments lookup

NICHOLAS BANKER: Open Payments

NPI 1770060071 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,983 in 122 payments from 16 companies in 2025. Trend: 2023 $1,201 · 2024 $1,405 · 2025 $1,983

Food & beverage: $1,983
CompanyPaymentsAmount
ABBVIE INC.36$410
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)22$361
Neurocrine BioSciences, Inc.10$251
Alkermes, Inc.10$231
Tris Pharma Inc20$171
Takeda Pharmaceuticals U.S.A., Inc.8$159
Otsuka America Pharmaceutical, Inc.5$112
E.R. Squibb & Sons, L.L.C.2$59
Axsome Therapeutics, Inc.2$51
Vanda Pharmaceuticals Inc.1$37

Products named: VRAYLAR, CAPLYTA, INGREZZA, LYBALVI, Dyanavel XR, TRINTELLIX, REXULTI, COBENFY.

Industry payments across NY — which companies pay providers there.